By: Editorial Staff, Date: October 18th, 2024
The Hatch-Waxman Act has effectively fostered competition in the pharmaceutical market by streamlining the approval process for generic drugs while balancing the need for innovation among brand-name manufacturers. Discover how the Hatch-Waxman Act has transformed access to affordable medicines and reshaped the pharmaceutical industry in this infographic.
Discover more insights at our webcast: Hatch-Waxman Case-Law Developments and New Jersey Practice Insights
Upcoming Webcasts
ITC Litigation and Enforcement: Recent Legal Issues and Compliance Strategies Explored
The US International Trade Commission (ITC) remains the avenue for investigating complex intellectual property (IP)-related disputes. Successful representation at the ITC draws heavily on strategic capabilities to handle intricate claims and high-stake investigations.